AEGLEA BIOTHERAPEUTICS INC (AGLE)

US00773J2024 - Common Stock

12.01  +0.97 (+8.79%)

After market: 11.88 -0.13 (-1.08%)

Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to AGLE. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 17.85. This target is 48.63% above the current price.
AGLE was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about AGLE.
In the previous month the buy percentage consensus was at a similar level.
AGLE was analyzed by 9 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 12.0112.1217.8517.8524.15 - 0.92% 48.63% 48.63% 101.08%
Up and Down Grades
Date Firm Action Rating
2023-08-16 Wells Fargo Maintains Equal-Weight -> Equal-Weight
2023-07-25 Stifel Initiate Buy
2023-04-12 LifeSci Capital Downgrade Outperform -> Market Perform
2023-04-12 JonesTrading Downgrade Buy -> Hold
2023-03-03 HC Wainwright & Co. Maintains Neutral
2022-10-28 Wells Fargo Upgrade Equal-Weight -> Overweight
2022-08-09 Wells Fargo Maintains Equal-Weight
2022-06-03 Needham Downgrade Buy -> Hold
2022-06-03 HC Wainwright & Co. Downgrade Buy -> Neutral
2022-05-23 Piper Sandler Maintains Overweight
2022-05-06 Needham Maintains Buy